We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
78 hedge funds and large institutions have $206M invested in Rocket Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
81% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 16
40% more capital invested
Capital invested by funds: $147M → $206M (+$59.4M)
18% more funds holding
Funds holding: 66 → 78 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
89% less call options, than puts
Call options by funds: $447K | Put options by funds: $4.08M
Holders
78
Holders Change
+12
Holders Change %
+18.18%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
29
Reduced
16
Closed
5
Calls
$447K
Puts
$4.08M
Net Calls
-$3.63M
Net Calls Change
-$3.65M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$3.6M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.87M |
| 3 |
Millennium Management
New York
|
+$1.73M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.66M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.34M |
